Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
128 participants
OBSERVATIONAL
2025-04-20
2025-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinesiophobia in Postmenopausal Osteoporosis
NCT06520709
How Vertebral Fractures Effect Balance In Postmenopausal Women
NCT06502301
Balance and Muscle Strength as Indicators of Fracture Risk in Postmenopausal Women
NCT06645600
An Assessment of Treatment Adherence of Osteoporosis Patients From a Biopsychosocial Perspective
NCT05943600
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60
NCT07045012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
* Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
* Willingness to participate and provision of written informed consent.
Exclusion Criteria
* Diagnosed psychiatric disorders.
* Cognitive impairment.
* Presence of malignancy.
* Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
* Use of glucocorticoids.
* Use of medications affecting mood.
55 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beylikduzu State Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Busra Sirin
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beylikdüzü State Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Beylikdüzüstateh17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.